BR100 Increased By (0.21%)
BR30 Increased By (0.21%)
KSE100 Increased By (0.24%)
KSE30 Increased By (0.2%)
AGHA 6.50 Increased By ▲ 0.05 (0.78%)
BECO 4.18 Increased By ▲ 0.02 (0.48%)
BML 56.25 Decreased By ▼ -1.06 (-1.85%)
BOP 28.29 Increased By ▲ 0.14 (0.5%)
CNERGY 12.53 Increased By ▲ 0.12 (0.97%)
CSIL 5.40 Increased By ▲ 0.04 (0.75%)
FCCL 51.50 Decreased By ▼ -0.16 (-0.31%)
FFL 13.89 Decreased By ▼ -0.01 (-0.07%)
FNEL 1.09 Increased By ▲ 0.01 (0.93%)
KEL 5.70 Decreased By ▼ -0.02 (-0.35%)
KOSM 5.32 Decreased By ▼ -0.01 (-0.19%)
LOTCHEM 24.39 Increased By ▲ 0.14 (0.58%)
MLCF 89.75 Increased By ▲ 0.11 (0.12%)
NBP 156.96 Increased By ▲ 0.39 (0.25%)
NCPL 49.62 Increased By ▲ 2.60 (5.53%)
NPL 55.00 Increased By ▲ 3.04 (5.85%)
OGDC 299.92 Decreased By ▼ -0.09 (-0.03%)
PACE 9.30 Increased By ▲ 0.04 (0.43%)
PAEL 33.09 Increased By ▲ 0.08 (0.24%)
PIBTL 13.22 Increased By ▲ 0.03 (0.23%)
PPL 214.23 Decreased By ▼ -0.09 (-0.04%)
PRL 100.25 Decreased By ▼ -1.19 (-1.17%)
PTC 52.35 Increased By ▲ 0.11 (0.21%)
SSGC 23.20 Increased By ▲ 0.05 (0.22%)
TBL 9.05 Decreased By ▼ -0.04 (-0.44%)
TELE 7.03 Increased By ▲ 0.05 (0.72%)
TPL 22.41 Increased By ▲ 0.37 (1.68%)
TPLP 11.75 Increased By ▲ 0.06 (0.51%)
TREET 22.99 Increased By ▲ 0.19 (0.83%)
TRG 57.52 Increased By ▲ 0.39 (0.68%)
World

Singapore approves COVID-19 vaccine for children ages 5 to 11

Published Updated
By

SINGAPORE: Singapore will start COVID-19 vaccinations for children aged 5 to 11 years before the end of this year, its health ministry said late on Friday.

The Southeast Asian city-state has already vaccinated 87% of its 5.5 million populations, and authorities were rushing to get children vaccinated amid concerns over rising number of paediatric COVID-19 cases.

AstraZeneca to supply COVID-19 antibody cocktail to Singapore

The dosage used for children will be one-third of that used in adults, similar to the United States.

Currently, only Pfizer-BioNTech "Comirnaty" vaccine has been approved for children's usage in Singapore, the health ministry added.

Singapore has also signed a new supply agreement with Pfizer-BioNTech for the COVID-19 vaccine, it said, without specifying how many vials will be supplied.

Comments

Comments are closed for this article.